![](https://cdn.sanity.io/images/0vv8moc6/curetoday/83281ab521e9150301c405f5248aea0f0a521999-644x280.jpg?fit=crop&auto=format)
OBX-115 Receives FDA Fast Track Designation in Advanced Melanoma
The Food and Drug Administration (FDA) has granted a Fast Track Designation to OBX-115 for the treatment of patients with metastatic (cancer that has spread from where it started to other parts of the body) or locally advanced (cancer that has spread from …